Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
KP Research Radio talks to Ai Kubo, PhD, MPH, about her research into why girls are starting puberty earlier than they have in the past, risks associated with early puberty — and potential interventions.
A large, detailed look by Kaiser Permanente researchers at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.
Andy Avins, MD, MPH, has been studying what works, and what doesn't, in medical care ever since a chance encounter in the hospital library with a journal that introduced him to the concept of evidence-based medicine.
Kaiser Permanente research shows the need for increased education about the dangers of high blood pressure.
New study by research scientist Ai Kubo, MPH, PhD, adds to the evidence suggesting a link between early life family structure and onset of puberty.
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
Early career researcher Marvin Langston, PhD, MPH, studies potential links between infections, inflammation, and cancer as well as racial/ethnic and sexual minority health disparities.
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.